223514-63-4 Usage
Uses
Used in Pharmaceutical Industry:
(S)-N-(1-(4-chloromethylphenyl)ethyl)acetamide is used as an intermediate for the synthesis of pharmaceutical drugs, contributing to the development of new medications.
Used in Organic Chemistry:
(S)-N-(1-(4-chloromethylphenyl)ethyl)acetamide is used as a building block in the creation of new organic compounds, expanding the scope of chemical research and applications.
Used in Asymmetric Synthesis:
(S)-N-(1-(4-chloromethylphenyl)ethyl)acetamide is used as a single enantiomer in asymmetric synthesis, which is crucial for producing enantiomerically pure compounds with specific biological activities.
Used in Drug Development:
It is employed as a modulating agent in the development of new drug molecules, potentially leading to the creation of more effective and targeted therapies.
Used in Biological Research:
(S)-N-(1-(4-chloromethylphenyl)ethyl)acetamide is used as a tool to study the biological effects of chiral molecules and their interactions with biological receptors, enhancing our understanding of molecular biology and pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 223514-63-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,5,1 and 4 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 223514-63:
(8*2)+(7*2)+(6*3)+(5*5)+(4*1)+(3*4)+(2*6)+(1*3)=104
104 % 10 = 4
So 223514-63-4 is a valid CAS Registry Number.
223514-63-4Relevant articles and documents
Piperazine compounds and medicinal use thereof
-
, (2008/06/13)
The present invention relates to a piperazine compound of the formula wherein R1and R2are each hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, nitro, hydroxy or cyano, R3, R4and R5are each hydrogen, halogen, lower alkyl, lower alkoxy, nitro, amino, substituted amino or hydroxy, R6and R7are each hydrogen, lower alkyl, lower alkyl substituted by halogen, aralkyl, acyl or lower acyl substituted by halogen, R8and R9are each hydrogen or lower alkyl, Y is lower alkylene and the like, and ring A is phenyl, pyrimidyl, thiazolyl, pyridyl, pyrazyl or imidazolyl, a pharmaceutically acceptable salt thereof and pharmaceutical agents containing these compounds. The compound of the present invention has superior TNF-α production inhibitory effect and/or IL-10 production promoting effect, and, since it is free of or shows only strikingly reduced expression of an effect on the central nervous system, the compound is useful as a highly safe and superior TNF-α production inhibitor an/or IL-10 production promoter and is useful as an agent for the prophylaxis or treatment of various diseases caused by abnormal TNF-α production, diseases curable with IL-10, such as chronic inflammatory diseases, acute inflammatory diseases, inflammatory diseases due to infection, autoimmune diseases, allergic diseases, and TNF-α mediated diseases.
